A Delaware federal judge on Monday threw out a $45 million damages award for genetic testing company CareDx in a false-advertising case against rival Natera .
A federal judge in Delaware said on Monday that 10x Genomics and Harvard University must face antitrust counterclaims over their licensing practices in two gene-analysis patent lawsuits.
Nepal judiciary needs revitalisation to save its sanctity onlinekhabar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onlinekhabar.com Daily Mail and Mail on Sunday newspapers.
3 Min Read
(Reuters) - Bio-Rad Laboratories has settled its patent infringement claims against French biotech company Stilla Technologies three days after the start of a trial in Boston federal court, according to a court filing.
A seal hangs over a building at Harvard University in Cambridge, Massachusetts. REUTERS/Jessica Rinaldi
The trial over Stilla’s alleged infringement of patents owned by Bio-Rad, Harvard University and others related to microfluidic genetic analysis technology began June 30, and the parties informed the court of the settlement July 3, according to a Wednesday order.
Details of the settlement weren’t immediately available.
Bio-Rad, Stilla, and Stilla’s attorney Juanita Brooks of Fish & Richardson didn’t immediately respond to a request for comment. Bio-Rad’s attorney Ed Reines of Weil Gotshal & Manges declined to comment.